IRIS UniCatt

Coco, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.222
EU - Europa 3.113
AS - Asia 2.610
SA - Sud America 513
AF - Africa 66
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 9.542
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.148
SG - Singapore 1.212
DE - Germania 1.091
CN - Cina 739
SE - Svezia 531
IT - Italia 444
BR - Brasile 429
FR - Francia 209
UA - Ucraina 198
IN - India 164
IE - Irlanda 145
GB - Regno Unito 139
VN - Vietnam 111
ID - Indonesia 89
FI - Finlandia 83
TR - Turchia 67
RU - Federazione Russa 64
HK - Hong Kong 40
PL - Polonia 40
AT - Austria 38
BE - Belgio 37
MX - Messico 34
JP - Giappone 31
BD - Bangladesh 30
AR - Argentina 28
CA - Canada 28
NL - Olanda 28
ZA - Sudafrica 22
KR - Corea 20
IQ - Iraq 19
ES - Italia 12
CI - Costa d'Avorio 11
VE - Venezuela 11
CZ - Repubblica Ceca 10
EC - Ecuador 10
RO - Romania 10
UZ - Uzbekistan 10
LT - Lituania 9
AE - Emirati Arabi Uniti 8
PE - Perù 8
SA - Arabia Saudita 8
CL - Cile 7
CO - Colombia 7
PK - Pakistan 7
AU - Australia 6
IL - Israele 6
IR - Iran 6
JO - Giordania 6
KE - Kenya 6
UY - Uruguay 6
PH - Filippine 5
SN - Senegal 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DK - Danimarca 4
DZ - Algeria 4
LV - Lettonia 4
MA - Marocco 4
AM - Armenia 3
AZ - Azerbaigian 3
BO - Bolivia 3
CH - Svizzera 3
ET - Etiopia 3
EU - Europa 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PA - Panama 3
PY - Paraguay 3
BB - Barbados 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
PG - Papua Nuova Guinea 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AL - Albania 1
AQ - Antartide 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
Totale 9.533
Salva come PNG Salva come JPEG
Città #
Chandler 571
Singapore 540
Ashburn 279
Beijing 149
Dublin 145
Ann Arbor 121
Jacksonville 119
New York 115
San Mateo 101
Hefei 86
Nanjing 84
Jakarta 79
Los Angeles 78
Milan 77
Munich 74
Nürnberg 70
Wilmington 67
Cattolica 65
Hyderabad 57
Boston 52
Marseille 51
São Paulo 51
Houston 49
Izmir 48
Frankfurt am Main 45
Dearborn 42
Princeton 40
Rome 40
Dallas 38
Ho Chi Minh City 38
Brussels 36
Moscow 35
Woodbridge 35
Hong Kong 34
Chicago 32
Lawrence 31
Nanchang 30
Hanoi 28
Redwood City 28
Bremen 25
Buffalo 25
Seattle 24
Tokyo 24
Kent 21
Brooklyn 20
Nuremberg 20
Santa Clara 20
Stockholm 20
Fairfield 19
London 19
Seoul 19
Vienna 19
Norwalk 18
The Dalles 18
Zhengzhou 18
Helsinki 17
Boardman 16
Lancaster 16
Shenyang 16
Turku 16
Warsaw 16
Denver 15
Phoenix 15
San Francisco 15
Düsseldorf 14
Tianjin 14
Atlanta 13
Hebei 13
Johannesburg 13
Kunming 13
Mountain View 13
Shanghai 13
Belo Horizonte 12
Columbus 12
Guangzhou 12
Lauterbourg 12
Orem 12
Abidjan 11
Jiaxing 11
Lappeenranta 11
Leawood 11
Washington 11
Changsha 10
Council Bluffs 10
Curitiba 10
Kraków 10
Tashkent 10
Toronto 10
Wroclaw 10
Bexley 9
Brasília 9
Detroit 9
Rio de Janeiro 9
Verona 9
Ankara 8
Cambridge 8
Charlotte 8
Cuauhtémoc 8
Da Nang 8
Jinan 8
Totale 4.515
Salva come PNG Salva come JPEG
Nome #
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 247
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 225
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 194
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 169
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 169
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 168
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 164
Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli 164
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 161
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 161
Polyvinylidene Fluoride Mesh (PVDF, DynaMesh®-IPOM) in The Laparoscopic Treatment of Incisional Hernia: A Prospective Comparative Trial versus Gore® ePTFE DUALMESH® Plus. 159
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 158
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 158
Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection 157
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 157
Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey 149
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 145
Advance in diagnosis and treatment of small bowel tumors: a single-center report 141
Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery? 141
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer 132
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients 129
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. 128
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 124
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 123
Familial microsatellite-stable non-polyposis colorectal cancer: incidence and characteristics in a clinic-based population 122
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 122
[D-Ala2,D-Leu5]-enkephalin (DADLE) and morphine-induced postconditioning by inhibition of mitochondrial permeability transition pore, in human myocardium 120
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 116
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 116
Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study 116
Effectiveness and Validation of the Italian Translation of the Low Anterior Resection Syndrome Score in an Italian High-Volume University Hospital 114
Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience. 113
BRIDGE -1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial 112
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 111
Tumor size as a prognostic factor in patients with stage IIa colon cancer 110
Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. 109
CT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. 108
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes 107
RESTAGING LOCALLY ADVANCED RECTAL CANCER WITH MR IMAGING AFTER CHEMORADIATION THERAPY 105
Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the “Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network” (SICO-CCN) multicentre collaborative study 102
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 100
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 99
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 98
Anastomosis configuration and technique following ileocaecal resection for Crohn’s disease: a multicentre study 98
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 97
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study 97
Effectiveness and Validation of the Italian Translation of the Low Anterior Resection Syndrome Score in an Italian High-Volume University Hospital 95
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 95
Preoperative chemoradiotherapy affects postoperative outcomes and functional results in patients treated with transanal endoscopic microsurgery for rectal neoplasms 95
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 94
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis 93
Surgical treatment of small bowel neoplasms. 92
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper. 90
Body mass index and complications following major gastrointestinal surgery: A prospective, international cohort study and meta-analysis 85
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) 83
T1 colon cancer in the era of screening: risk factors and treatment 82
Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study 80
Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines 80
Gastro-intestinal symptoms as clinical manifestation of peritoneal and retroperitoneal spread of an invasive lobular breast cancer: Report of a case and review of the literature 80
National variations in perioperative assessment and surgical management of Crohn’s disease: a multicentre study 80
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer 79
Practice parameters for early rectal cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines 77
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper 77
Segmental transverse colectomy. Minimally invasive versus open approach: results from a multicenter collaborative study 76
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial 75
Correction to: Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer (Annals of Surgical Oncology, (2021), 28, 5, (2801-2808), 10.1245/s10434-020-09243-6) 75
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 73
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer 73
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial 72
Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients 71
Four steps in the evolution of rectal cancer managements through 40 years of clinical practice: Pioneering, standardization, challenges and personalization 69
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 68
Neutrophil to lymphocyte ratio predicts risk of nodal involvement in T1 colorectal cancer patients 68
Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial 66
Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study. 66
Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer after Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome 60
Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer 58
Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): A nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group 57
Rectal Sparing Approach after preoperative Radio- and/or Chemo-therapy (ReSARCh): a prospective, multicenter, observational study 57
Global variation in the long-term outcomes of ypT0 rectal cancers 56
Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients 56
Association of Delayed Surgery with Oncologic Long-term Outcomes in Patients with Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation 55
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis 55
Segmental Colonic Resection Is a Safe and Effective Treatment Option for Colon Cancer of the Splenic Flexure: A Nationwide Retrospective Study of the Italian Society of Surgical Oncology-Colorectal Cancer Network Collaborative Group 55
Minimally invasive vs. open segmental resection of the splenic flexure for cancer: a nationwide study of the Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CNN) 54
Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: Prognostic factors and long term outcome 52
Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy 51
Oncological outcomes of patients not undergoing Total Mesorectal Excision after local excision: rethinking surgical indications 51
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 50
Textbook Outcome in Colorectal Surgery for Cancer: An Italian Version 50
MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer 49
Surgeons' fear of getting infected by COVID19: A global survey 47
Laparoscopic approach to recurrent incisional hernia repair: A 3-year experience 46
Role and Morbidity of Protective Ileostomy after Anterior Resection for Rectal Cancer: One Centre Experience and Review of Literature 44
Split course concomitant radiochemotherapy followed by brachytherapy boost in the exclusive treatment of the anal canal cancer 43
The prognostic role of anatomo-pathological factors in colorectal cancer: an univariate analysis 34
Combined-modality therapy in locally advanced primary rectal cancer 32
Other tumours of the colon and rectum 27
Rectal sparing approach after preoperative radio - and/or Chemo-therapy (ReSARCh): a prospective, multicentre, observational study 9
Totale 9.672
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.063
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021291 0 0 0 0 0 21 60 15 78 33 69 15
2021/2022717 62 39 12 87 29 30 8 93 21 49 155 132
2022/20231.478 216 212 93 248 79 189 75 121 165 20 33 27
2023/2024691 38 206 20 50 46 112 27 10 8 18 80 76
2024/20251.798 26 45 130 72 210 78 84 81 226 194 353 299
2025/20262.488 675 138 298 515 811 51 0 0 0 0 0 0
Totale 9.672